A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.5K citations

Nafld Activity Score, Diagnosis, Pathology +24

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Paul Angulo, David E. Kleiner, Sanne Dam‐Larsen et al. · Gastroenterology · 2015 · 2.9K citations · Full text

Metabolic Associated Steatohepatitis, Fibrosis, Hepatology +14

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Mattias Ekstedt, Hannes Hagström, Patrik Nasr et al. · Hepatology · 2014 · 2.2K citations · Full text

Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis

Liang‐Guo Xu · Gut · 2004 · 1K citations · Full text

World Gastroenterology Organisation Global Guidelines

Douglas R. LaBrecque, Zaigham Abbas, Frank A. Anania et al. · Journal of Clinical Gastroenterology · 2014 · 517 citations